Investigators explored the timing of immunosuppression tapering and predictors of discontinuation in patients with lupus nephritis.

Study findings add to the evidence supporting the utility of tacrolimus for the clinical management of patients with lupus nephritis.

A case study shows how a therapy typically used for cancer could be adapted to treat a disorder that Céline Dion recently ...

reflecting these new risks and a higher discount rate applied to the company’s valuation due to the cash overhang and a reduced probability of success in the Lupus Nephritis program. Furthermore, ...

Conduit Pharmaceuticals announces plans to initiate Phase 2a trials in both systemic lupus erythematosus and ANCA-associated vasculitis for its lead clinical candidate, AZD1656AZD1656, a HK-4 ...

Psoriatic arthritis can develop slowly and cause mild symptoms, or it can develop quickly and aggressively. Some people may ...

Equillium Inc. (Nasdaq: EQ), a clinical-stage biotechnology company leveraging a deep understanding of immunobiology to ...

Infection-related hospitalizations accounted for the majority of in-hospital mortalities among children and adolescents with cSLE.

Century Therapeutics (IPSC) has received a new Hold rating, initiated by William Blair analyst, Sami Corwin. Sami Corwin has given his Hold ...

Since the 1950s, researchers have used a famous method invented by Wallace Coulter known as "flow cytometry" to characterize ...

(HealthDay News) — Direct oral anticoagulant (DOAC) prescribing oversight for off-label prescribing is beneficial while patients are prescribed DOAC, according to a study published online in ...

Vertex Pharmaceuticals has consistently outperformed the S&P 500 and iShares Biotechnology ETF. See why VRTX stock is a Buy.